Correlation between Intracellular and Extracellular Lysozyme in Acute (Myelo)Monocytic Leukemia

N Saito1

  • 1a The Third Department of Internal Medicine, Hokkaido University School of Medicine, Sapporo, Japan.

Leukemia & Lymphoma
|July 27, 2016
PubMed

Insights

Elevated serum lysozyme in leukemia patients is linked to degranulation of lysozyme-positive granules from viable leukemic cells. Myeloperoxidase (MPO) is released concurrently with lysozyme.

Area of Science:

  • Hematology
  • Cell Biology
  • Biochemistry

Background:

  • Acute (myelo)monocytic leukemia is characterized by elevated serum lysozyme activity.
  • The underlying mechanism for this increase in lysozyme levels remains unclear.

Purpose of the Study:

  • To investigate the cellular localization of myeloperoxidase (MPO) and lysozyme in leukemic cells.
  • To elucidate the mechanism behind elevated serum lysozyme in acute (myelo)monocytic leukemia.

Main Methods:

  • Electron microscopy was used to examine leukemic cell specimens.
  • Localization of MPO and lysozyme within leukemic cells was analyzed.

Main Results:

  • Lysozyme and MPO were found in granules at the periphery of leukemic cell cytoplasm.
  • Granules appeared to undergo degranulation from the cell membrane of viable cells.
  • MPO-positive granules were identified as containing lysozyme.

Conclusions:

  • Degranulation of lysozyme-positive granules from viable leukemic cells is a likely mechanism for elevated serum lysozyme.
  • Myeloperoxidase (MPO) is co-released into the serum with lysozyme.

Related Concept Videos